To Beyond Celiac, a cure means real treatment options so those with celiac disease can live healthy lives and eat without fear.
Our mission has evolved to one of advancing the science of celiac disease because we firmly believe that with a strategic approach to funding-focused research, an effective treatment or cure could be possible by 2030. To accomplish that goal, we are laser-focused on addressing the many current barriers.
We have created a science department led by a Chief Science and Strategy Officer to determine the highest and best use of our resources in driving new treatments for people with celiac disease. We are focused on clinical advancements for our community.
Beyond Celiac is staffed with highly qualified professionals—the right people in the right positions to fulfill our mission.
We have assembled a multi-disciplinary group of leaders in celiac disease research to advise us on how to achieve maximum impact.
Members include scientists and physicians with backgrounds in the research and treatment of celiac disease, immunology, mucosal biology, pharmaceutical research, and other associated specialties.
The large, diverse celiac disease community continues to suffer from high daily burdens in coping with the disease, and we need treatments and a cure. Beyond Celiac has crafted its science plan to change the future for the 3.2 million Americans living with this serious genetic autoimmune disorder.
Through Go Beyond Celiac and other initiatives, we are collecting and analyzing comprehensive data on the burden of celiac disease and gluten sensitivity. With this information, we can increase awareness and make a compelling case for larger investments from government agencies, pharmaceutical companies, biotech and more.
How we’re collecting/analyzing data:
We are funding promising research that quickly translates from scientific investigation to clinical use, speeding the development of treatments for patients.
Learn more about the innovative research we’re currently funding:
As the nation’s top recruiter for celiac disease clinical trials, we will continue educating our community about the importance of participating in trials. We will also work with pharmaceutical companies to ensure trials are designed with patient perspectives in mind.
Learn more about how we’re assisting clinical trials:
We will invest significant resources to identify treatments that have been investigated or approved for other purposes but might also benefit celiac disease patients, reducing risk, cost and time to market for potential celiac disease treatments.
Download: The Beyond Celiac Science Plan infographic.
Beyond Celiac partners with pharmaceutical, health and biotech companies and organizations to advance our shared goals of unlocking celiac disease and accelerating a cure.
We embrace and leverage strategic partnerships and strong collaborations to advance our plan priorities, overcome challenges and maximize progress toward a cure.
Contact us to learn more about partnership opportunities.